Anti-gonadotrophin releasing hormone vaccine (ML Laboratories/Protherics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-gonadotrophin releasing hormone vaccine (ML Laboratories/Protherics)
Drug Alias NameO14LGnRHiGnRH vaccine - ML Laboratories/ProthericsGnRH immunotherapeuticProlog +[6] 
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunostimulantsEstrogen receptors antagonistsProgesterone receptor antagonists +[4] 
TargetsEstrogen receptorsGonadotropin-releasing hormoneProgesterone receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProtherics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProthericsMl Laboratories Plc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A